Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001193125-25-335482

President and CEO sold 9,922 shares at $10.01 ($99,319)

From the SEC's structured data for this filing

Trades in this filing

AHMED NADIM · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-12-23 Sale : show line 1 in the form −9,922 $10.01 $99,319 420,699 D
Open-market sales · 9,922 sh · avg $10.01 · $99,319
Loading xslF345X05/ownership.xml…